hims glp-1 news & Hers to offer access to compounded injections for as low as $99/month to first responders Hims & Hers, and the

It is biological, not a willpower problem, driven by dysregulation in GLP-1, leptin, and ghrelin pathways

Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association

You might think any small needle will do

confirm at checkout What's included (brand-stated): medication, clinician visits, dose adjustments, portal messaging, free overnight shipping - no separate membership fee per brand disclosure Compounding status: Compounded semaglutide and tirzepatide are not FDA-approved finished drug products

Journal of General Internal Medicine, February 2001

The LEAN-PREP study and the GRAMS trial at Pennington Biomedical Research Center are both recruiting as of 2026 specifically to study GLP-1's effects on muscle and the interventions that can preserve it